Equitas Small Finance Bank Ltd

Operational commencement at new Chennai office

• Operations at the new corporate office have commenced in a phased relocation.
• New corporate office address: Equitas Towers, Mount Road, Little Mount, Saidapet, Chennai 600015.
• Registered Office remains at Spencer Plaza, Mount Road, Chennai; no address change.
• Specified departments relocated as part of phased transition.
• In continuation of Sept 7, 2026 intimation, inauguration of the new office occurred.

NCD issue and listing details

• Listing approval received on 29 Sep 2026 for private placement of 50,000 Lower Tier II NCDs.
• Issuance size Rs 500 crore; face value Rs 1,00,000 per NCD.
• ISIN INE063P08138; listing date 29 Sep 2026; exchange BSE Limited.
• First interest payment due 25 Sep 2027; no payment made yet.
• Interest Rs 9,950 per debenture; annual frequency.
• Redemption at maturity on 25 Sep 2036; outstanding amount Rs 500 crore.
• Credit ratings: CARE AA- (Stable) and IND AA- (Stable).
• Payment status: no interest payment yet; debentures allotted 25 Sep 2026; no defaults.

Key Update

• Aggregate GST assessment reduced from Rs 533,81,24,251 to Rs 23,95,12,141 after September 25, 2026 hearing.
• Breakdown: tax Rs 21,67,28,670; interest Rs 11,10,604; penalty Rs 2,16,72,867; eligible for exemption.

Equitas Small Finance Bank Ltd trading window closed from October 01, 2026 till 48 hours after the announcement of the Unaudited Financial Results for the quarter and half year ending September 30, 2026

Capital / Securities

• Allotted 50,000 Lower Tier II NCDs on private placement.
• Aggregate value Rs 500 crore.
• Face value Rs 1,00,000 per NCD.
• Instrument: unsecured, subordinated, transferable, redeemable, fully paid-up Lower Tier II bonds.
• Issue type: private placement.
• Tenure: 10 years; maturity on 25 September 2036.
• Date of allotment: 25 September 2026.
• Coupon rate: 9.95% per annum.
• Listed on BSE Limited.
• Issuer: Equitas Small Finance Bank Limited.

Cessation of Independent Director

• Cessation as Independent Director effective from close of business hours September 22, 2026, on completion of term.

Key Update

• Bank received GST DRC-01 SCN on Sep 21, 2026 for FY2022-23 with total demand of Rs 533.81 crore.
• Disallowance relates largely to exemption on interest income; Bank contends it is exempt, except credit-card interest.
• SCN is show-cause stage; the Bank will respond with reconciliations within the prescribed timeline.

Event details

• Date and duration: Sep 21, 2026, 10:00 AM–4:00 PM
• Organizer: Kotak Securities Limited; one-to-one in-person meetings
• Participants: existing/prospective investors and analysts
• Presentation: investor presentation hosted on bank website
• No unpublished price sensitive information is proposed to be shared
• Schedule subject to change due to investor/bank exigencies

Capital raise via NCD issue

• Board approves private placement of NCDs up to Rs 500 crore.
• Up to 50,000 NCDs of Rs 1 lakh each.
• NCDs are unsecured, rated, subordinated, and redeemable.
• NCDs to be listed on BSE; dematerialized form.
• Issuance to be in a single series; private placement to eligible investors.
• Face value Rs 1 lakh; aggregate size up to Rs 500 crore.
• Capital qualifies as Basel II Lower Tier II capital.
• Tenor and coupon to be decided by the Board.

AGM Details

• AGM held on 9 September 2026 via VC/OAVM.
• Remote e-voting open 6–8 September 2026.
• Record date 2 September 2026.
• Start time 11:00 AM, end time 12:06 PM.

Key Resolutions

• Item 1: Ordinary—Adoption of Audited Financial Statements.
• Item 2: Ordinary—Re-appointment of Balaji Nuthalapadi as director.
• Item 3: Ordinary—Appointment of Sundaram & Srinivasan as Joint Statutory Auditors.
• Item 4: Ordinary—Remuneration payable to Joint Statutory Auditors for 2026-27.
• Item 5: Ordinary—Re-appointment of Vasudevan P N as MD & CEO.
• Item 6: Ordinary—Remuneration payable to Vasudevan P N as MD & CEO.
• Item 7: Ordinary—Remuneration payable to Balaji Nuthalapadi as Executive Director.
• Item 8: Special—Re-appointment of Geeta Dutta Goel as Independent Director.
• Item 9: Special—Issuance of redeemable debt securities via private placement.
• Item 10: Special—QIP up to Rs 1,250 crores.

Voting Results

• Item 1: Passed; strong majority in favour.
• Item 2: Passed; minimal opposition.
• Item 3: Passed; negligible against votes.
• Item 4: Passed; minimal against.
• Item 5: Passed; high in-favour.
• Item 6: Passed; high in-favour.
• Item 7: Passed; high in-favour.
• Item 8: Special—Passed; 3x more in favour.
• Item 9: Special—Passed; 3x more in favour.
• Item 10: Special—Passed; 3x more in favour.

Dividend

• No dividend proposed or declared.

Directors

• Vasudevan P N re-appointed as MD & CEO for 3-year term.
• Geeta Dutta Goel re-appointed as Independent Director for 3-year term.
• Balaji Nuthalapadi re-appointed after rotation.

Auditors

• Sundaram & Srinivasan appointed as Joint Statutory Auditors; term until 13th AGM.
• Remuneration for Joint Statutory Auditors approved for 2026-27.

Capital Raising

• Debt securities up to 500 crores approved.
• Qualified Institutions Placement up to 1,250 crores approved.

Related Party Transactions

• No material related party transactions approved.